PRGO - PERRIGO Co plc
Close
25.61
-0.010 -0.039%
Share volume: 0
Last Updated: Thu 26 Dec 2024 02:30:08 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
15.72%
PREVIOUS CLOSE
CHG
CHG%
$25.62
-0.01
-0.04%
Fundamental analysis
23%
Profitability
7%
Dept financing
34%
Liquidity
73%
Performance
24%
Performance
5 Days
-0.43%
1 Month
-9.72%
3 Months
0.35%
6 Months
0.16%
1 Year
-19.12%
2 Year
-22.35%
Key data
Stock price
$25.61
DAY RANGE
N/A - N/A
52 WEEK RANGE
$24.42 - $34.60
52 WEEK CHANGE
-$20.00
DIVIDEND
$0.276
EX-DIVIDEND DATE
08/30/2024
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Murray S. Kessler
Region: US
Website: perrigo.com
Employees: 8,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: perrigo.com
Employees: 8,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being. The company operates through two segments, Consumer Self-Care Americas and Consumer Self Care International. Its products include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh and Burt's Bees brand names.
Recent news